Literature DB >> 15494815

Prevalence of osteoporosis among postmenopausal females with diabetes mellitus.

Mohamed A Al-Maatouq1, Mahmoud I El-Desouki, Saleh A Othman, Essam H Mattar, Zainab A Babay, Mohammed Addar.   

Abstract

OBJECTIVE: To assess the prevalence of osteopenia and osteoporosis among Saudi postmenopausal women with non-insulin dependent type 2 diabetes mellitus (T2DM).
METHODS: The study was carried out at King Khalid University Hospital, Riyadh, Kingdom of Saudi Arabia from February 2000 to September 2002. Bone mineral density (BMD) of the lumbar spine and femoral neck using dual x-ray absorptiometry (DXA; Lunar Wisconsin), were performed in 104 postmenopausal Saudi women with T2DM, and 101 postmenopausal non-diabetic women (control). Bone mineral density was measured in gm/cm2 and both T-score and Z-score were measured but only T-score was used for analysis based on World Health Organization criteria. Bone profile, 25(OH) Vitamin D, 1,25(OH)2 Vitamin D, parathyroid hormone and urine deoxypyridinoline (DPD) were measured in most patients and controls. Body fat measurement around the biceps muscles using Futrex (body composition analyzer) were performed in patients and controls. Years postmenopausal, duration of diabetes mellitus, parity, exercise, sun exposure and milk consumption were also recorded.
RESULTS: In the diabetic group, the mean spine BMD was 0.928 gm/cm2 (T-score = -2.28 SD) and for femoral neck the mean BMD was 0.817 gm/cm2 (T-score = -1.21 SD). In control group, the mean spine BMD was 1.036 gm/cm2 (T-score = -1.2) and mean femoral neck BMD was 0.914 gm/cm2 (T-score = -0.608). In the diabetic group, there was 16 (16.64%) patients with normal BMD of the spine, 42 patients (43.68%) with osteopenia (mean T-score = -1.8 SD) and 45 (46.8%) with osteoporosis (mean T-score = -3.3 SD).
CONCLUSION: Osteoporosis is more common among Type 2 postmenopausal females in this ethnic group. Since both groups are postmenopausal, having equal percentage of Vitamin D deficiency, multi-parity, non exposure to sun, lack of exercise and negligible milk intake, one can conclude that the low BMD can be attributed to DM in the absence of other causes of osteoporosis.

Entities:  

Mesh:

Year:  2004        PMID: 15494815

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  16 in total

Review 1.  Bone health and type 2 diabetes mellitus: a systematic review.

Authors:  Erin Gorman; Anna M Chudyk; Kenneth M Madden; Maureen C Ashe
Journal:  Physiother Can       Date:  2011-01-20       Impact factor: 1.037

2.  Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies.

Authors:  Lili Ma; Ling Oei; Lindi Jiang; Karol Estrada; Huiyong Chen; Zhen Wang; Qiang Yu; Maria Carola Zillikens; Xin Gao; Fernando Rivadeneira
Journal:  Eur J Epidemiol       Date:  2012-03-27       Impact factor: 8.082

Review 3.  Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis.

Authors:  P Vestergaard
Journal:  Osteoporos Int       Date:  2006-10-27       Impact factor: 4.507

Review 4.  Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.

Authors:  Kathryn M Thrailkill; Charles K Lumpkin; R Clay Bunn; Stephen F Kemp; John L Fowlkes
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11       Impact factor: 4.310

5.  Promoting culturally targeted chronic disease prevention research through an adapted participatory research approach: The Qassim-Stanford Universities project.

Authors:  Sandra J Winter; Abby C King; Randall S Stafford; Marilyn A Winkleby; William L Haskell; John W Farquhar
Journal:  Transl Behav Med       Date:  2011-06       Impact factor: 3.046

6.  Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilization.

Authors:  J A Sunyecz; L Mucha; O Baser; C E Barr; M M Amonkar
Journal:  Osteoporos Int       Date:  2008-03-20       Impact factor: 4.507

7.  Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study.

Authors:  D von Muhlen; S Safii; S K Jassal; J Svartberg; E Barrett-Connor
Journal:  Osteoporos Int       Date:  2007-05-11       Impact factor: 4.507

8.  The relationship among renal injury, changed activity of renal 1-alpha hydroxylase and bone loss in elderly rats with insulin resistance or Type 2 diabetes mellitus.

Authors:  C-Q Huang; G-Z Ma; M-D Tao; X-L Ma; Q-X Liu; J Feng
Journal:  J Endocrinol Invest       Date:  2009-03       Impact factor: 4.256

9.  Effect of oral hypoglycaemic agents on bone metabolism in patients with type 2 diabetes mellitus & occurrence of osteoporosis.

Authors:  B Siddhartha Kumar; A Ravisankar; Alladi Mohan; D Prabath Kumar; D T Katyarmal; Alok Sachan; K V S Sarma
Journal:  Indian J Med Res       Date:  2015-04       Impact factor: 2.375

10.  Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?

Authors:  Shaymaa Abdalwahed Abdulameer; Syed Azhar Syed Sulaiman; Mohamed Azmi Ahmad Hassali; Karuppiah Subramaniam; Mohanad Naji Sahib
Journal:  Patient Prefer Adherence       Date:  2012-06-11       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.